Wednesday, March 18, 2015

400 Percent Cost Difference to Treat Prostate Disease

UCLA researchers have for the first time described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using time-driven activity-based costing. They found a 400 percent discrepancy between the least and most expensive ways to treat the condition. (UCLA Health)
Why does this persist?

Read the entire column at NCPA's Health Policy Blog.

No comments: